Evaluating the accuracy of American Society for Gastrointestinal Endoscopy guidelines in patients with acute gallstone pancreatitis with choledocholithiasis

Table 5 Demographics of gallstone pancreatitis patients with intermediate and high risk for choledocholithiasis

	Intermediate risk (n = 79)	High risk (n = 77)	P value
Age (yr) mean ± SD	58.6 ± 19.2	58.1 ± 17.3	0.86
BMI (kg/m2) mean ± SD	29.0 ± 6.83	29.6 ± 9.82	0.05
Female	44 (60%)	45 (58%)	0.95
Race			0.70
White	50 (72%)	51 (68%)
Black	15 (22%)	15 (20%)
Other	4 (6%)	9 (12%)
Charlson Comorbidity Index			0.60
0	17 (23%)	19 (25%)
1 to 2	24 (33%)	20 (26%)
3 to 5	21 (29%)	29 (38%)
6 and above	11 (15%)	9 (12%)
Baseline laboratory
Creatinine (mg/dL) mean ± SD	0.98 ± 0.55	0.94 ± 0.68	0.71
White blood cell count (K/L) mean ± SD	11.4 ± 4.64	12.1 ± 7.27	0.49
Lactate (mmol/L) mean ± SD	1.60 ± 1.33	1.75 ± 1.44	0.63
Lipase (IU/L) mean ± SD	4012 ± 5264	3576 ± 4699	0.60
ALT (IU/L) mean ± SD	241 ± 269	335 ± 324	0.06
AST (IU/L) mean ± SD	232 ± 280	294 ± 269	0.18
Alkaline phosphatase (IU/L) mean ± SD	156 ± 130	196 ± 140	0.07
Total bilirubin (mg/dL) mean ± SD	1.32 ± 0.78	4.04 ± 2.06	< 0.01
Presence of gallstone on imaging	79 (100%)	77 (100%)	0.91
Severity of pancreatitis
Mean BISAP ± SD	0.90 ± 0.91	0.88 ± 0.88	0.90
Modified Atlanta Criteria			0.13
Mild	57 (72%)	63 (83%)
Moderate	21 (27%)	10 (13%)
Severe	1 (1%)	3 (4%)

BMI: Body mass index; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; BISAP: Bedside index of severity in acute pancreatitis.